Insider · CIK 0001314575

Beer Marc D

Reports to the SEC for 5 companies · IRVING, TX

sec.gov

Transactions

Companies

Filings

CIK

0001314575

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-11	BTMDbiote Corp.P Purchase	Director, Executive Chairman	PPurchase	+16K sh	$1.55	+$24.8K	239,744
2026-08-10	BTMDbiote Corp.P Purchase	Director, Executive Chairman	PPurchase	+116K sh	$1.53	+$177K	223,744
2026-06-08	BTMDbiote Corp. · Employee Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+114K sh	—	—	114,157
2026-05-12	BTMDbiote Corp. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+195K sh	—	—	195,000
2025-04-01	BTMDbiote Corp. · Employee Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+496K sh	—	—	495,600
2025-03-17	BTMDbiote Corp.P Purchase	Director, Executive Chairman	PPurchase	+108K sh	$3.87	+$417K	107,794
2024-04-01	BTMDbiote Corp. · Employee Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+544K sh	—	—	1,338,842
2023-05-17	BTMDbiote Corp. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+317K sh	—	—	794,884
2023-01-09	BTMDbiote Corp.S Sale	Director, Executive Chairman	SSale	−865K sh	$3.00	−$2.6M	0
2023-01-06	BTMDbiote Corp. · Retained Biote UnitsC Conversion	Director, Executive Chairman	CConversion	−865K sh	—	—	2,967,092
2023-01-06	BTMDbiote Corp.C Conversion	Director, Executive Chairman	CConversion	+865K sh	—	—	865,384
2023-01-06	BTMDbiote Corp.J Other	Director, Executive Chairman	JOther	−865K sh	—	—	2,967,092
2022-11-15	BTMDbiote Corp. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+478K sh	—	—	477,721
2022-11-15	BTMDbiote Corp. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+478K sh	—	—	477,721
2022-05-26	BTMDbiote Corp. · Retained Biote UnitsJ Other	Director, Executive Chairman	JOther	+654K sh	—	—	3,832,476
2022-05-26	BTMDbiote Corp.J Other	Director, Executive Chairman	JOther	+654K sh	—	—	3,832,476
2022-05-26	BTMDbiote Corp. · Retained Biote UnitsJ Other	Director, Executive Chairman	JOther	+654K sh	—	—	3,832,769
2022-05-26	BTMDbiote Corp. · Retained Biote UnitsA Award	Director, Executive Chairman	AAward	+3.18M sh	—	—	3,178,089
2022-05-26	BTMDbiote Corp.J Other	Director, Executive Chairman	JOther	+654K sh	—	—	3,832,769
2022-05-26	BTMDbiote Corp.A Award	Director, Executive Chairman	AAward	+3.18M sh	—	—	3,178,089
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+128K sh	—	—	127,513
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80.4K sh	—	—	0
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80.4K sh	—	—	80,356
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2018-01-31	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−128K sh	—	—	0
2017-06-01	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-03-20	NERVMinerva Neurosciences, Inc.P Purchase	Director	PPurchase	+25K sh	$7.89	+$197K	50,000
2017-03-17	NERVMinerva Neurosciences, Inc.P Purchase	Director	PPurchase	+25K sh	$8.34	+$209K	25,000
2016-06-16	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2015-04-01	Aegerion Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+33K sh	—	—	33,000
2015-04-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+133K sh	—	—	133,000
2015-02-02	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-02-02	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2014-12-31	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+120K sh	—	—	120,000
2014-08-28	Aegerion Pharmaceuticals, Inc.G Gift	Director, Chief Executive Officer	GGift	−769 sh	—	—	78,631
2014-07-31	Aegerion Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+7,700 sh	$33.44	+$257K	77,100
2014-07-31	Aegerion Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,300 sh	$34.37	+$79.1K	79,400
2014-06-30	NERVMinerva Neurosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+128K sh	—	—	127,513
2014-03-26	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−3,000 sh	—	—	739,273
2014-03-26	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3,000 sh	$1.54	+$4,620	3,000
2013-12-04	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+4,380 sh	$1.54	+$6,745.2	4,380
2013-12-04	Aegerion Pharmaceuticals, Inc.G Gift	Director, Chief Executive Officer	GGift	−4,380 sh	—	—	0
2013-12-04	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−4,380 sh	—	—	742,273
2013-11-05	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−39K sh	—	—	746,653
2013-11-05	Aegerion Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+39K sh	$1.54	+$60.1K	234,726

Recent filings

Accepted (ET)
Aug 124
Beer Marc D0001314575-26-000007
SEC(opens sec.gov)
Jun 104
Beer Marc D0001314575-26-000004
SEC(opens sec.gov)
May 134
Beer Marc D0001314575-26-000002
SEC(opens sec.gov)
Apr 24
Beer Marc D0001562180-25-002908
SEC(opens sec.gov)
Mar 184
Beer Marc D0001415889-25-008527
SEC(opens sec.gov)
Apr 34
Beer Marc D0001562180-24-003276
SEC(opens sec.gov)
May 194
Beer Marc D0001562180-23-004324
SEC(opens sec.gov)
Jan 104
Beer Marc D0001209191-23-002786
SEC(opens sec.gov)
Nov 184/A
Beer Marc D0001209191-22-057828
SEC(opens sec.gov)
Nov 164
Beer Marc D0001209191-22-057300
SEC(opens sec.gov)
Sep 194/A
Beer Marc D0001209191-22-050492
SEC(opens sec.gov)
May 314
Beer Marc D0001209191-22-033032
SEC(opens sec.gov)

Companies

Address

C/O BIOTE CORP. 1875 W. WALNUT HILL LN #100

IRVING, TX, 75038